StockData
Panacea Life Sciences Holdings, Inc. logo

Panacea Life Sciences Holdings, Inc. (PLSH) stock

PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Panacea Life Sciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Panacea Life Sciences's operating income for the twelve months ending Mar 31, 2024 was -$5.31M. For fiscal 2023 it was -$5.55M. The highest annual figure on record is -$389.28K in fiscal 2015.

Annual operating income

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$5.55M–
FY2022Dec 31, 2022-$5.65M–
FY2021Dec 31, 2021-$5.94M–
FY2020Dec 31, 2020-$5.26M–
FY2019Dec 31, 2019-$10.67M–
FY2018Dec 31, 2018-$2.44M–
FY2017Dec 31, 2017-$3.12M–
FY2016Dec 31, 2016-$1.60M–
FY2015Dec 31, 2015-$389.28K–
FY2014Dec 31, 2014-$420.26K–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2024Mar 31, 2024-$1.06M–
Q4 FY2023Dec 31, 2023-$1.77M–
Q3 FY2023Sep 30, 2023-$1.41M–
Q2 FY2023Jun 30, 2023-$1.07M–
Q1 FY2023Mar 31, 2023-$1.29M–
Q4 FY2022Dec 31, 2022-$1.38M–
Q3 FY2022Sep 30, 2022-$1.39M–
Q2 FY2022Jun 30, 2022-$1.24M–
Q1 FY2022Mar 31, 2022-$1.65M–
Q4 FY2021Dec 31, 2021-$2.15M–
Q3 FY2021Sep 30, 2021-$1.26M–
Q2 FY2021Jun 30, 2021-$1.44M-279.3%
Q1 FY2021Mar 31, 2021-$1.09M–
Q4 FY2020Dec 31, 2020-$1.72M–
Q3 FY2020Sep 30, 2020-$3.35M–
Q2 FY2020Jun 30, 2020$802.64K–
Q1 FY2020Mar 31, 2020-$2.63M–
Q4 FY2019Dec 31, 2019-$4.95M–
Q3 FY2019Sep 30, 2019-$2.02M–
Q2 FY2019Jun 30, 2019-$2.02M–
Q1 FY2019Mar 31, 2019-$2.60M–
Q4 FY2018Dec 31, 2018-$584.70K–
Q3 FY2018Sep 30, 2018-$425.93K–
Q2 FY2018Jun 30, 2018-$296.20K–
Q1 FY2018Mar 31, 2018-$1.38M–
Q4 FY2017Dec 31, 2017-$1.53M–
Q3 FY2017Sep 30, 2017-$490.21K–
Q2 FY2017Jun 30, 2017-$506.30K–
Q1 FY2017Mar 31, 2017-$601.01K–
Q4 FY2016Dec 31, 2016-$747.43K–
Q3 FY2016Sep 30, 2016-$359.81K–
Q2 FY2016Jun 30, 2016-$260.87K–
Q1 FY2016Mar 31, 2016-$233.37K–
Q4 FY2015Dec 31, 2015-$69.65K–
Q1 FY2015Mar 31, 2015-$64.02K–
Q4 FY2014Dec 31, 2014-$240.45K–
Q3 FY2014Sep 30, 2014-$74.89K–
Q2 FY2014Jun 30, 2014-$17.10K–

More Panacea Life Sciences figures

See a number that looks wrong?